Avastin: updated statement on its use for the treatment of wet AMD

The recent judicial review ruling finds the use of Avastin (bevacizumab) in the NHS for the treatment of wet AMD to be lawful. Whilst we recognise the financial savings that could be made by switching
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news